{"id":16216,"date":"2020-06-09T19:09:39","date_gmt":"2020-06-09T17:09:39","guid":{"rendered":"https:\/\/asscat-hepatitis.org\/?p=16216"},"modified":"2020-06-09T19:09:39","modified_gmt":"2020-06-09T17:09:39","slug":"gilead-reivindica-el-seu-compromis-amb-les-malalties-hepatiques-malgrat-la-crisi-de-la-covid-19","status":"publish","type":"post","link":"https:\/\/asscat-hepatitis.org\/ca\/gilead-reivindica-el-seu-compromis-amb-les-malalties-hepatiques-malgrat-la-crisi-de-la-covid-19\/","title":{"rendered":"Gilead reivindica el seu comprom\u00eds amb les malalties hep\u00e0tiques malgrat la crisi de la COVID-19"},"content":{"rendered":"<p>[et_pb_section bb_built=&#8221;1&#8243; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;3.0.106&#8243; custom_margin=&#8221;|||&#8221; custom_padding=&#8221;0px||0px|&#8221; next_background_color=&#8221;#000000&#8243;][et_pb_row custom_padding=&#8221;0px||0px|&#8221; _builder_version=&#8221;3.0.106&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221;][et_pb_column type=&#8221;4_4&#8243;][et_pb_post_title author=&#8221;off&#8221; date_format=&#8221;d\/m\/Y&#8221; comments=&#8221;off&#8221; featured_placement=&#8221;background&#8221; text_background=&#8221;on&#8221; text_bg_color=&#8221;#ffffff&#8221; module_class=&#8221;ac-post-title-section-0&#8243; _builder_version=&#8221;3.0.106&#8243; title_font=&#8221;Montserrat|600|||||||&#8221; title_text_color=&#8221;#2d2d2d&#8221; title_letter_spacing=&#8221;-1px&#8221; title_line_height=&#8221;1.2em&#8221; meta_font=&#8221;Open Sans||||||||&#8221; meta_text_color=&#8221;rgba(45,45,45,0.5)&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;|||&#8221; custom_padding=&#8221;|20px|20px|20px&#8221; title_text_align=&#8221;center&#8221; meta_font_size=&#8221;13px&#8221; meta_text_align=&#8221;center&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_post_title][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section bb_built=&#8221;1&#8243; _builder_version=&#8221;3.0.106&#8243; custom_padding=&#8221;||0px|&#8221; prev_background_color=&#8221;#000000&#8243; module_class=&#8221;ac-post-section-share-rrss&#8221; next_background_color=&#8221;#000000&#8243;][et_pb_row custom_padding=&#8221;||0px|&#8221; custom_margin=&#8221;|||&#8221; _builder_version=&#8221;3.0.105&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221;][et_pb_column type=&#8221;4_4&#8243;][et_pb_divider color=&#8221;#e20611&#8243; show_divider=&#8221;on&#8221; divider_style=&#8221;ridge&#8221; _builder_version=&#8221;3.0.106&#8243; \/][et_pb_text _builder_version=&#8221;3.0.106&#8243; text_font=&#8221;Montserrat||||||||&#8221; text_text_color=&#8221;#e20611&#8243; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||0px|&#8221; custom_padding=&#8221;|||&#8221; background_layout=&#8221;light&#8221; disabled=&#8221;on&#8221;]<\/p>\n<h5>Desde aqu\u00ed puedes compartir esta publicaci\u00f3n. \u00a1Gracias!<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section bb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.0.106&#8243; custom_padding=&#8221;0px|||&#8221; prev_background_color=&#8221;#000000&#8243;][et_pb_column type=&#8221;2_3&#8243; specialty_columns=&#8221;2&#8243;][et_pb_row_inner admin_label=&#8221;Fila&#8221; _builder_version=&#8221;3.0.106&#8243;][et_pb_column_inner type=&#8221;4_4&#8243; saved_specialty_column_type=&#8221;2_3&#8243;][et_pb_text admin_label=&#8221;Contenido Entrada 1&#8243; ul_type=&#8221;square&#8221; module_class=&#8221;ac-posts-content&#8221; _builder_version=&#8221;3.0.106&#8243; text_orientation=&#8221;justified&#8221; background_layout=&#8221;light&#8221;]<\/p>\n<h3>La companyia farmac\u00e8utica Gilead ha participat en el I Congr\u00e9s Virtual Digestiu de la Societat Espanyola de Patologia Digestiva (SEPD) reafirmant el seu elevat comprom\u00eds amb les malalties hep\u00e0tiques i inflamat\u00f2ries intestinals, les societats cient\u00edfiques i els metges experts en aquestes especialitats malgrat el context de pand\u00e8mia actual.<\/h3>\n<p>En el marc del Congr\u00e9s, Gilead ha organitzat dues taules rodones, en les quals ha abordat q\u00fcestions d\u2019import\u00e0ncia com l\u2019eliminaci\u00f3 de l\u2019hepatitis C al nostre pa\u00eds, aix\u00ed com per l\u2019aposta per la telemedicina com a eina per a seguiment dels pacients. Des de la implementaci\u00f3 del PEAHC (Pla Estrat\u00e8gic per a l\u2019Abordatge de l\u2019Hepatitis C) al Sistema Nacional de Salut (SNS) el 2015, s\u2019han tractat m\u00e9s de 130.000 pacients. No obstant, i com es publica en el document de posicionament de l\u2019Associaci\u00f3 Espanyola per a l\u2019Estudi del Fetge (AEEH) sobre l\u2019eliminaci\u00f3 de l\u2019eliminaci\u00f3 de l\u2019hepatitis C, malgrat a les excel\u00b7lents dades, s\u2019estima que en l\u2019\u00e0mbit de la poblaci\u00f3 general que assisteix a l\u2019atenci\u00f3 prim\u00e0ria hi ha encara 76.500 persones vir\u00e8miques.<\/p>\n<p>En una de les taules rodones, el doctor Conrado Fern\u00e1ndez, de l\u2019Hospital Universitario Fundaci\u00f3n Alcorc\u00f3n de Madrid, ha destacat que es troben davant <em>\u201ccertes dificultats per trobar a la poblaci\u00f3 infectada pel virus C ja que alguns d\u2019aquests pacients estan apartats del sistema de salut, s\u00f3n poblaci\u00f3 vulnerable molt dif\u00edcil d\u2019arribar-hi mitjan\u00e7ant campanyes de prevenci\u00f3 i conscienciaci\u00f3 social\u201d<\/em>. <em>\u201cPer aix\u00f2, les societats cient\u00edfiques i metges especialistes necessitem que hi hagi un sistema de vigil\u00e0ncia adequat i s\u2019implantin t\u00e8cniques de cribratge en totes les persones amb edats compreses entre els 40 i 70 anys. Es calcula que el 80% de la poblaci\u00f3 visita al metge un cop a l\u2019any, per aix\u00f2, seria una bona oportunitat aprofitar aquestes consultes per realitzar-los un test serol\u00f2gic\u201d<\/em>, ha proposat.<\/p>\n<p>Al llarg de la sessi\u00f3, els experts han reconegut l\u2019esfor\u00e7 realitzat en els \u00faltims anys per aconseguir l\u2019eliminaci\u00f3 del virus, per\u00f2 han alertat de la import\u00e0ncia de seguir conscienciant a la poblaci\u00f3 sobre la necessitat d\u2019identificar i tractar a tots els pacients amb hepatitis C. Posar el focus en el diagn\u00f2stic preco\u00e7, la cerca activa i el posterior tractament de totes les persones que estiguin infectades pel virus de l\u2019hepatitis C, aix\u00ed com el desenvolupament de projectes de microeliminaci\u00f3, s\u00f3n claus per aconseguir l\u2019objectiu de l\u2019eliminaci\u00f3 total de la malaltia pel 2021.<\/p>\n<p>A m\u00e9s, durant aquest I Congr\u00e9s Virtual de la SEPD, Gilead ha impulsat una segona taula rodona en qu\u00e8 el doctor Joaqu\u00edn Cabezas Gonz\u00e1lez, de l\u2019Hospital Universitario Marqu\u00e9s de Valdecilla de Santander, ha explicat l\u2019important paper de la telemedicina en el maneig dels pacients amb hepatitis C a la pres\u00f3 de \u2018El Dueso\u2019, pionera en la utilitzaci\u00f3 d\u2019aquesta t\u00e8cnica a Espanya. <em>\u201cEl que va comen\u00e7ar el 2015 com un projecte de telemedicina, avui \u00e9s la pr\u00e0ctica habitual. En aquests moments els interns amb infecci\u00f3 VHC activa s\u00f3n aquells casos incidents que ingressen al centre penitenciari. Dins d\u2019ella, no hem detectat casos de reinfecci\u00f3, no nom\u00e9s pel cribratge sistem\u00e0tic i acc\u00e9s al tractament antiviral, sin\u00f3 per la integraci\u00f3 amb els programes de reducci\u00f3 de danys (intercanvi de xeringues, ter\u00e0pia substitutiva d\u2019opioides)\u201d<\/em>, ha detallat.<\/p>\n<p>Es tracta d\u2019una pr\u00e0ctica amb molt bona acollida per part dels interns, preservant la seva autoestima, evitant l\u2019estigmatitzaci\u00f3 i, a m\u00e9s, <em>\u201csuposa un estalvi pel sistema a l\u2019evitar costos com el despla\u00e7aments dels presos, servei d\u2019escortes, burocr\u00e0cia administrativa, etc.\u201d<\/em>, ha afirmat el doctor Cabeza, que ha incidit tamb\u00e9 en la import\u00e0ncia de normalitzar la telemedicina al SNS i la seva utilitzaci\u00f3 com engranatge de contacte amb la resta dels estaments del sistema sanitari. Segons els experts, gr\u00e0cies a la telemedicina, els projectes de microeliminaci\u00f3 i les t\u00e8cniques de diagn\u00f2stic preco\u00e7, l\u2019objectiu de l\u2019eliminaci\u00f3 de l\u2019hepatitis C est\u00e0 molt m\u00e9s a prop i pot ser una realitat.<\/p>\n<p>&nbsp;<\/p>\n<p>Font: <a href=\"https:\/\/www.infosalus.com\/farmacia\/noticia-gilead-reivindica-compromiso-enfermedades-hepaticas-pese-crisis-covid-19-20200601133703.html\">infosalus.com<\/a><\/p>\n<p>Not\u00edcia tradu\u00efda per l\u2019ASSCAT<\/p>\n<p>[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner admin_label=&#8221;Fila&#8221; custom_padding=&#8221;0px|||&#8221; _builder_version=&#8221;3.0.105&#8243; custom_margin=&#8221;|||&#8221;][et_pb_column_inner type=&#8221;4_4&#8243; saved_specialty_column_type=&#8221;2_3&#8243;][et_pb_post_title admin_label=&#8221;Metadatos &#8211; Fecha \u00daltima actualizaci\u00f3n&#8221; title=&#8221;off&#8221; author=&#8221;off&#8221; date_format=&#8221;d\/m\/Y&#8221; categories=&#8221;off&#8221; comments=&#8221;off&#8221; featured_image=&#8221;off&#8221; _builder_version=&#8221;3.0.106&#8243; title_text_align=&#8221;left&#8221; meta_font=&#8221;Open Sans||||||||&#8221; meta_text_align=&#8221;left&#8221; meta_font_size=&#8221;13px&#8221; meta_text_color=&#8221;#0082ca&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#cccccc&#8221; custom_margin=&#8221;50px|||&#8221; custom_padding=&#8221;10px|||&#8221; custom_css_before=&#8221;content:%22\u00daltima actualizaci\u00f3n:%22;&#8221; global_module=&#8221;3449&#8243; saved_tabs=&#8221;all&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_post_title][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243;][et_pb_sidebar orientation=&#8221;right&#8221; area=&#8221;et_pb_widget_area_8&#8243; module_class=&#8221;ac-posts-sidebar&#8221; _builder_version=&#8221;3.0.106&#8243; global_module=&#8221;3198&#8243; saved_tabs=&#8221;all&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_sidebar][\/et_pb_column][\/et_pb_section]<\/p>\n<!-- Begin Yuzo --><div class='yuzo_related_post style-1'  data-version='5.12.77'><!-- without result --><div class='yuzo_clearfixed yuzo__title yuzo__title'><h3>Related Post<\/h3><\/div>\n\t\t\t\t\t\t  <div class=\"relatedthumb \" style=\"width:125px;float:left;overflow:hidden;\">  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <a  href=\"https:\/\/asscat-hepatitis.org\/ca\/el-fetge-gras-no-alcoholic-pot-disparar-els-casos-de-cancer-hepatic\/\"  >\n\t\t\t\t\t\t\t\t\t  <div class=\"yuzo-img-wrap \" style=\"width: 125px;height:90px;\">\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"yuzo-img\" style=\"background:url('https:\/\/asscat-hepatitis.org\/wp-content\/uploads\/el-higado-graso-no-alcoholico-puede-disparar-los-casos-de-cancer-hepatico-7049_620x368-150x150.jpg') 50% 50% no-repeat;width: 125px;height:90px;margin-bottom: 5px;background-size: cover; \"><\/div>\n\t\t\t\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t\t   <span class=\"yuzo__text--title\" style=\"font-size:13px;\">El fetge gras no alcoh\u00f2lic pot disparar els casos ...<\/span>\n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <\/a>\n\n\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t  <div class=\"relatedthumb \" style=\"width:125px;float:left;overflow:hidden;\">  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <a  href=\"https:\/\/asscat-hepatitis.org\/ca\/sofosbuvir-ledipasvir-cura-a-la-majoria-dels-nens-petits-amb-hepatitis-c\/\"  >\n\t\t\t\t\t\t\t\t\t  <div class=\"yuzo-img-wrap \" style=\"width: 125px;height:90px;\">\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"yuzo-img\" style=\"background:url('https:\/\/asscat-hepatitis.org\/wp-content\/uploads\/nin\u0303os-150x150.jpg') 50% 50% no-repeat;width: 125px;height:90px;margin-bottom: 5px;background-size: cover; \"><\/div>\n\t\t\t\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t\t   <span class=\"yuzo__text--title\" style=\"font-size:13px;\">Sofosbuvir \/ ledipasvir cura a la majoria dels nen...<\/span>\n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <\/a>\n\n\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t  <div class=\"relatedthumb \" style=\"width:125px;float:left;overflow:hidden;\">  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <a  href=\"https:\/\/asscat-hepatitis.org\/ca\/dema-comenca-a-lovain-la-neuve-brussel%c2%b7les-el-congres-del-premi-nordmann-esbra-2018-sobre-lalcohol-i-el-sistema-immunologic\/\"  >\n\t\t\t\t\t\t\t\t\t  <div class=\"yuzo-img-wrap \" style=\"width: 125px;height:90px;\">\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"yuzo-img\" style=\"background:url('https:\/\/asscat-hepatitis.org\/wp-content\/uploads\/esbra-150x150.jpeg') 50% 50% no-repeat;width: 125px;height:90px;margin-bottom: 5px;background-size: cover; \"><\/div>\n\t\t\t\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t\t   <span class=\"yuzo__text--title\" style=\"font-size:13px;\">Dem\u00e0 comen\u00e7a a Lovain-la-Neuve (Brussel\u00b7les) el Co...<\/span>\n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <\/a>\n\n\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t  <div class=\"relatedthumb \" style=\"width:125px;float:left;overflow:hidden;\">  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <a  href=\"https:\/\/asscat-hepatitis.org\/ca\/quarta-sessio-pacient-expert-en-hepatologia-2020\/\"  >\n\t\t\t\t\t\t\t\t\t  <div class=\"yuzo-img-wrap \" style=\"width: 125px;height:90px;\">\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"yuzo-img\" style=\"background:url('https:\/\/asscat-hepatitis.org\/wp-content\/uploads\/HCC-4\u00aa-sessio\u0301-Pacient-Expert-150x150.jpg') 50% 50% no-repeat;width: 125px;height:90px;margin-bottom: 5px;background-size: cover; \"><\/div>\n\t\t\t\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t\t   <span class=\"yuzo__text--title\" style=\"font-size:13px;\">Quarta sessi\u00f3 Pacient Expert en Hepatologia 2020<\/span>\n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <\/a>\n\n\t\t\t\t\t\t  <\/div>\n<\/div> <style>\n\t\t\t\t\t\t\t\t.yuzo_related_post img{width:120px !important; height:110px !important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb{line-height:15px;background: !important;color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb:hover{background:#fcfcf4 !important; -webkit-transition: background 0.2s linear; -moz-transition: background 0.2s linear; -o-transition: background 0.2s linear; transition: background 0.2s linear;;color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb a{color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb a:hover{ color:}!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb:hover a{ color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .yuzo_text {color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb:hover .yuzo_text {color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb{  margin: 0px  0px  0px  0px;   padding: 5px  5px  5px  5px;  }\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/style> <script>\n\t\t\t\t\t\t  jQuery(document).ready(function( $ ){\n\t\t\t\t\t\t\t\/\/jQuery('.yuzo_related_post').equalizer({ overflow : 'relatedthumb' });\n\t\t\t\t\t\t\tjQuery('.yuzo_related_post .yuzo_wraps').equalizer({ columns : '> div' });\n\t\t\t\t\t\t   })\n\t\t\t\t\t\t  <\/script> <!-- End Yuzo :) -->","protected":false},"excerpt":{"rendered":"<p>La companyia farmac\u00e8utica Gilead ha participat en el I Congr\u00e9s Virtual Digestiu de la Societat Espanyola de Patologia Digestiva (SEPD) reafirmant el seu elevat comprom\u00eds amb les malalties hep\u00e0tiques i inflamat\u00f2ries intestinals.<\/p>\n","protected":false},"author":9,"featured_media":16218,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[491],"tags":[6451,5457,5693,6452,1193,3768,3951,3107],"class_list":["post-16216","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-de-prensa-ca","tag-congres-virtual-sepd","tag-coronavirus-ca","tag-covid-19-ca","tag-gilead-siences","tag-malalties-hepatiques","tag-malalties-intestinals","tag-premsa-ca","tag-societats-cientifiques"],"_links":{"self":[{"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/posts\/16216","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/comments?post=16216"}],"version-history":[{"count":0,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/posts\/16216\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/media\/16218"}],"wp:attachment":[{"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/media?parent=16216"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/categories?post=16216"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/tags?post=16216"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}